Nexxana Bremelanotide: Exploring Online Treatment Options
What Is Nexxana Bremelanotide?
Nexxana Bremelanotide is a bremelanotide-based prescription product associated with Nexxana Desire. Nexxana Desire is a medication intended to treat women’s low sexual desire. Bremelanotide is a synthetic peptide acting on melanocortin receptors. It is also known as PT-141 and is the active ingredient in the FDA-approved prescription drug Vyleesi.
There is an important distinction between the active ingredient and the commercial treatment. In 2019, the FDA approved Vyleesi for acquired generalised hypoactive sexual desire disorder in premenopausal women distressed by low sexual desire. Such approval does not mean that each product or formulation sold under another brand is automatically separately approved by the FDA. Consumers should check the actual medication, formulation, prescribing arrangements and dispensing pharmacy.
Shop Now:
Comments
Post a Comment